PMR Online access    |   tel. +48 12 340 51 00    |   E-mail: info@pmrcorporate.com
 
 

Analyses


PMR Insight: Companies compete to develop biosimilar of Roche’s MabTheraClick and register to open this news

Roche (along with Genentech, a Roche subsidiary) has protection from competition for Mabthera and Rituxan (rituximab – a monoclonal antibody which targets CD20, used to treat B cell malignancies and B cell-mediated ... more »
2013-08-21
 

PMR Insight: Will Poland be an attractive market for research-based pharmaceutical firms?Click and register to open this news

Poland is a country of generics - and is likely to remain so in the immediate future. Part of the reason will be the substantial restrictions imposed by the Reimbursement Act, which made the situation of research-based ... more »
2013-08-19
 

Lower pharmacy sales in JuneClick and register to open this news

Pharmacy sales in Poland decreased modestly in June, both on a monthly and yearly basis. The value of drug reimbursement remained weak and there was a further softening of prices, while pharmacy margins improved. Overall ... more »
2013-08-16
 

What impact Russian uncertainty on CEE drug strategies?Click and register to open this news

Russian pharmaceutical sector development continues to follow an uneven path, with the government seemingly backing away from controversial reform in the second quarter of 2013. Elsewhere, other key drug markets ... more »
2013-08-15
 

WSE scraps NCX Life Science as part of NewConnect reformClick and register to open this news

The second quarter of 2013 was a period of unceasing declines and new lows for NewConnect, with the NCIndex, the main benchmark index of the Warsaw bourse’s junior board, slumping by 8.11% compared with Q1. The ... more »
2013-08-14
 

Licensed indications and reimbursement: where’s the rub?Click and register to open this news

One of the novelties introduced by the Reimbursement Act was to link reimbursement to licensed indications. Yet approved uses do not always reflect current medical knowledge, which doctors are under an obligation ... more »
2013-08-13
 

PMR Insight: Enterprise Investors to consolidate Polish radiotherapy services market Click and register to open this news

Enterprise Investors (EI), a private-equity (PE) group in the CEE region with a history of investment in healthcare, has decided to focus on the market subgroup of radiotherapy services in terms of its operations in ... more »
2013-08-07
 

PMR Insight: Increasing number of patients must buy reimbursed drugs at full priceClick and register to open this news

In 2012 there was a significant increase in the number of instances of reimbursed drugs being purchased for 100% of the price, according to IMS Health data presented during the Trade Marketing Farmaceutyczny conference ... more »
2013-08-06
 

PMR Insight: Reduction in pharmacy margins for reimbursed drugsClick and register to open this news

Polish pharmacies face a problem of declining margins for reimbursed drugs. This could lead to bankruptcies, as this group of medicines is crucial for revenues. IMS Health data presented during the Trade Marketing ... more »
2013-08-06
 

PMR Insight: Health expenditures in Poland account for 6.9% of GDPClick and register to open this news

According to the National Health Account published in July 2013 by the Central Statistical Office (GUS), in 2011 health expenditures (current expenditures and investments) accounted for 6.87% of gross domestic ... more »
2013-08-05
 

see more analytical articles  »

Browse and search in our archive »



 
Free e-letter with overview of news, analyses and reports from the pharmaceutical and healthcare sector in Poland, Russia and CEE.


Oncological pharmaceuticals and immunosuppressive drugs were the driving force pushing the growth of the pharmaceutical market in 2008-2009. The ... more »

W latach 2008-2009 r. leki onkologiczne i immunomodulujące były motorem wzrostu rynku leków. Główną tego przyczyną była zmiana statusu ... more »

The years 2013-2014 will be affected by the implications of the Reimbursement Act too, though the impact will be less severe than ... more »

Apteki internetowe wypracowały w 2012 r. wiele rozwiązań, które pozwalają zminimalizować zagrożenia związane z ustawą. Pierwszym z nich było ... more »

In 2010-2011 the economic crisis had a particularly adverse effect on the market covered by our analysis. According to industry ... more »
see more free articles »
 
 

Useful links         Privacy Policy
Copyright © 2017 PMR. All rights reserved.

PMR is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern Europe as well as other emerging markets. PMR key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research). Being present on the market since 1995, employing highly skilled staff, offering high international standards in projects and publications, providing one of most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.